Eli Lilly (LLY) Invested Capital (2016 - 2025)
Historic Invested Capital for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $69.0 billion.
- Eli Lilly's Invested Capital rose 5842.03% to $69.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $69.0 billion, marking a year-over-year increase of 5842.03%. This contributed to the annual value of $69.0 billion for FY2025, which is 5842.03% up from last year.
- Eli Lilly's Invested Capital amounted to $69.0 billion in Q4 2025, which was up 5842.03% from $66.4 billion recorded in Q3 2025.
- Eli Lilly's 5-year Invested Capital high stood at $69.0 billion for Q4 2025, and its period low was $23.4 billion during Q2 2022.
- Its 5-year average for Invested Capital is $36.3 billion, with a median of $30.0 billion in 2023.
- Its Invested Capital has fluctuated over the past 5 years, first plummeted by 758.68% in 2022, then soared by 5842.03% in 2025.
- Eli Lilly's Invested Capital (Quarter) stood at $25.9 billion in 2021, then decreased by 1.18% to $25.6 billion in 2022, then increased by 17.11% to $30.0 billion in 2023, then soared by 45.42% to $43.6 billion in 2024, then soared by 58.42% to $69.0 billion in 2025.
- Its Invested Capital was $69.0 billion in Q4 2025, compared to $66.4 billion in Q3 2025 and $54.2 billion in Q2 2025.